MARGENZA

MacroGenics, Inc.

Application Filed: 2018-07-05
Trademark Application Details
Trademark Logo MARGENZA

Mark For: MARGENZA® trademark registration is intended to cover the category of pharmaceutical preparations and substances for use in the treatment of cancer. [all]

Status

2021-07-17 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number88027290
Registration Number6364792
Mark Literal ElementsMARGENZA
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2021-04-21
Basis1(a)
Class StatusACTIVE
Primary US Classes
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseYes
Intent To UseNo
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameWilliam C. Schrot
Attorney Docket Number1301.5033T
Law Office AssignedM30
Employee NameMARTIN, LIEF ANDREW

Timeline

2018-07-05Application Filed
2018-10-25Location: TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED
2018-10-25Status: Live/Pending
2019-01-03Transaction Date
2019-04-30Published
2019-04-30Published for Opposition
2021-03-04Date of First Use
2021-03-04Date of Use In Commerce
2021-04-21Location: PUBLICATION AND ISSUE SECTION
2021-05-25Status: Registered. The registration date is used to determine when post-registration maintenance documents are due.
2021-05-25Trademark Registered

Trademark Parties (Applicants & Owners)

Party: MacroGenics, Inc.
Address9704 Medical Center Drive Rockville, MARYLAND UNITED STATES 20850
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

DrawingJPEG2018-07-05
TEAS RF New ApplicationMULTI2018-07-05
Notation to FileXML2018-10-24
XSearch Search SummaryXML2018-10-24
Offc Action OutgoingXML2018-10-25
Response to Office ActionXML2019-02-22
Amendment and Mail Process CompleteMULTI2019-02-23
TRAM Snapshot of App at Pub for OppostnMULTI2019-03-01
Publication & Issue Review CompleteMULTI2019-03-23
Notice of PublicationXML2019-04-10
Notification Of Notice of PublicationXML2019-04-10
OG Publication ConfirmationAPPLICATION/XML2019-04-30
Notice of AllowanceXML2019-06-25
Extension of Time to File SOUAPPLICATION/XML2019-12-11
ITU Extension ApprovalAPPLICATION/XML2019-12-13
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2019-12-13
Extension of Time to File SOUAPPLICATION/XML2020-05-28
ITU Extension ApprovalAPPLICATION/XML2020-05-30
ITU Unit ActionXML2020-05-30
Extension of Time to File SOUXML2020-12-14
ITU Extension ApprovalXML2020-12-16
ITU Unit ActionMULTI2020-12-16
SpecimenJPEG2021-03-16
Statement of UseMULTI2021-03-16
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2021-04-02
Notice of Acceptance of Statement of UseXML2021-04-22
TRAM Snapshot of App at Pub for OppostnAPPLICATION/XML,IMAGE/JPEG2021-04-22
Registration CertificatePDF2021-05-25

Attorney of Record

WILLIAM C. SCHROT
AUERBACHSCHROT LLC
2200 RESEARCH BLVD., STE. 560
ROCKVILLE, MD 20850

Good, Services, and Codes


IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances for use in the treatment of cancer. FIRST USE: 20210304. FIRST USE IN COMMERCE: 20210304

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations and substances for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Production and product commercialization for third parties of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Discovery, research, and development of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Discovery, research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and biotechnology
GS0051Pharmaceutical preparations and substances for use in the treatment of cancer

Trademark Filing History

DescriptionDateProceeding Number
REGISTERED-PRINCIPAL REGISTER2021-05-25
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED2021-04-22
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2021-04-21
STATEMENT OF USE PROCESSING COMPLETE2021-04-0171906
CASE ASSIGNED TO INTENT TO USE PARALEGAL2021-04-0171906
USE AMENDMENT FILED2021-03-1671906
TEAS STATEMENT OF USE RECEIVED2021-03-16
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-12-16
TEAS EXTENSION RECEIVED2020-12-14
EXTENSION 3 GRANTED2020-12-1498765
EXTENSION 3 FILED2020-12-1498765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-05-30
TEAS EXTENSION RECEIVED2020-05-28
EXTENSION 2 GRANTED2020-05-2898765
EXTENSION 2 FILED2020-05-2898765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-12-13
TEAS EXTENSION RECEIVED2019-12-11
EXTENSION 1 GRANTED2019-12-1198765
EXTENSION 1 FILED2019-12-1198765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-06-25
PUBLISHED FOR OPPOSITION2019-04-30
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-04-30
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-04-10
LAW OFFICE PUBLICATION REVIEW COMPLETED2019-03-2276568
ASSIGNED TO LIE2019-03-2276568
APPROVED FOR PUB - PRINCIPAL REGISTER2019-02-28
TEAS/EMAIL CORRESPONDENCE ENTERED2019-02-2288889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-02-22
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-02-2288889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2018-10-256325
NON-FINAL ACTION WRITTEN2018-10-2585328
NON-FINAL ACTION E-MAILED2018-10-256325
ASSIGNED TO EXAMINER2018-10-2485328
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-07-11
NEW APPLICATION ENTERED IN TRAM2018-07-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed